Betamethasone Sodium Phosphate

磷酸钠倍他米松

Report date: 2026/03/23 20:03:44
NME

Base Information

Drug NameBetamethasone Sodium Phosphate
Drug Alias Name倍他米松磷酸钠
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsAnaphylaxisAutoimmune DiseasesDry Eye Syndromes +[5] 
Global Approved IndicationsAnaphylaxisAutoimmune DiseasesBacterial Infections
Approved Indications in ChinaAnaphylaxisAutoimmune DiseasesBacterial Infections
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryUnited StatesEUMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesSurface Ophthalmics IncShionogi & Co LtdQiqiha'Er No 2 Pharmaceutical Factory
Inactive CompaniesN/A
Active IndicationsAnaphylaxisAutoimmune DiseasesDry Eye Syndromes +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeH02AB01
Related LinksN/A